共 50 条
- [2] LONG-TERM SURVIVAL OUTCOMES WITH INTRAVESICAL NANOPARTICLE ALBUMIN-BOUND PACLITAXEL FOR RECURRENT NON-MUSCLE INVASIVE BLADDER CANCER AFTER PREVIOUS BACILLUS CALMETTE-GUERIN THERAPY JOURNAL OF UROLOGY, 2017, 197 (04): : E247 - E248
- [3] Long-Term Survival Outcomes with Intravesical Docetaxel for Recurrent Nonmuscle Invasive Bladder Cancer After Previous Bacillus Calmette-Guerin Therapy JOURNAL OF UROLOGY, 2013, 189 (03): : 834 - 839
- [4] Re: Intravesical bacillus Calmette-Guerin with Interferon-Alpha versus Intravesical bacillus Calmette-Guerin for Treating Non-Muscle-Invasive Bladder Cancer Editorial Comment JOURNAL OF UROLOGY, 2018, 199 (03): : 608 - 609
- [5] A Phase I Trial of Intravesical Nanoparticle Albumin-Bound Paclitaxel in the Treatment of Bacillus Calmette-Guerin Refractory Nonmuscle Invasive Bladder Cancer JOURNAL OF UROLOGY, 2011, 186 (02): : 448 - 451
- [8] Intravesical Bacillus Calmette-Guerin with interferon-alpha versus intravesical Bacillus Calmette-Guerin for treating non-muscle-invasive bladder cancer COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (03):